Approval for the promus element plus everolimus-eluting platinum chromium coronary stent system. this device is indicated for improving luminal diameter in patients with symptomatic heart disease due to de novo lesions in native coronary arteries >=2.25 mm to <=4.00 mm in diameter in lesions <=28 mm inlength.